Female carriers of BRCA1/BRCA2 variants also have the additional high risk of ovarian cancer, with the cumulative lifetime risk in carriers of BRCA1 being 44% (36–53%), compared to BRCA2, which is 17% (11–25%) [62]. This evidence concerns the gene BRCA2 and ovarian carcinoma.